Dr. Jan Novák

Dr. Jan Novák is a senior medical oncologist at the Masaryk Memorial Cancer Institute (MMCI) in Brno, one of Central Europe's most respected dedicated cancer centres. With 19 years of oncological experience and a PhD in clinical oncology, he manages complex haematological malignancies and solid tumour oncology. MMCI is a WHO Collaborating Centre and one of the Czech Republic's principal cancer research institutions, and Dr. Novák is an active investigator in clinical trials. He is an ESMO member and contributes to European oncology education and guideline development. Trilingual in Czech, English, and German, he welcomes international patients seeking cancer second opinions or treatment at this internationally recognised centre.

Dr. Novák completed his MD at Masaryk University Faculty of Medicine in Brno and subsequently earned a PhD in clinical oncology with a focus on haematological malignancy biology. He completed an oncology fellowship at MMCI and undertook additional training at European partner cancer centres. He is an active ESMO member, regularly attending the ESMO Congress, and has participated in ESMO-endorsed clinical oncology training courses. His research has been published in peer-reviewed oncology journals.

Dr. Novák has deep expertise in the systemic treatment of lymphoma, multiple myeloma, colorectal, breast, and lung cancers, and leukaemia. He designs evidence-based chemotherapy, targeted therapy, and immunotherapy protocols and serves as principal investigator for oncology clinical trials at MMCI. He leads the hospital's haematological oncology tumour board and interprets bone marrow biopsy findings in coordination with haematopathologists. His practice integrates cutting-edge clinical trial access with rigorous personalised treatment planning.

Masaryk Memorial Cancer Institute is accustomed to receiving international patients seeking expert oncology opinion or cancer treatment in Central Europe. Dr. Novák consults in Czech, English, and German and is well positioned to provide second opinions for international patients. The institute offers structured international patient pathways including remote medical record review, video consultation, and coordinated treatment planning. Brno is well connected to Prague and other major European cities, facilitating access for visitors from across Europe.

Dr. Novák has received recognition from the Czech Society of Oncology for his contributions to clinical oncology practice and research. His clinical trial work at MMCI has contributed to internationally published evidence on lymphoma and myeloma treatment. He has been recognised by MMCI leadership for his excellence in tumour board leadership and his role in making international oncology expertise accessible to Czech and international patients.